Hierarchical Immunosuppression of Regional Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma

scientific article published on 01 October 1991

Hierarchical Immunosuppression of Regional Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/019459989110500403
P953full work available at URLhttp://journals.sagepub.com/doi/pdf/10.1177/019459989110500403
P698PubMed publication ID1762790

P2093author name stringM. B. Wang
A. Lichtenstein
R. A. Mickel
P2860cites workObservations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancerQ34194434
NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.Q39641278
Immunology of head and neck cancersQ40109770
Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapyQ41622603
First place--Resident Clinical Science Award 1990. Suppression of lymphokine-activated killer cell cytotoxicity by a soluble factor produced by squamous tumors of the head and neckQ41720182
Immunologic abnormalities in head and neck cancer.Q42439127
Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neckQ44496715
Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancerQ44862608
Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinomaQ45250241
Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.Q54390127
Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activityQ67294248
Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot studyQ68093427
The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancerQ68428612
Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinomaQ68721742
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytesQ68804520
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 aloneQ68815180
Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancerQ68830648
Natural cytotoxicity in draining lymph nodes of squamous cell cancer in the maxillofacial regionQ68981231
Miniaturization of the standard 51Cr release assay for long term follow-up of NK activity of individual miceQ69644437
Kinetic analysis of the inhibition of natural killer (NK) activity by multiple populations of tumor-activated suppressor cellsQ69881877
The glomerular permeability determined by dextran clearance using Sephadex gel filtrationQ72021219
Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patientsQ72771288
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectsurgeryQ40821
head and neck squamous cell carcinomaQ18348812
P304page(s)517-527
P577publication date1991-10-01
P1433published inOtolaryngology—Head and Neck SurgeryQ2646730
P1476titleHierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma
Hierarchical Immunosuppression of Regional Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma
P478volume105

Reverse relations

cites work (P2860)
Q41140197Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck
Q74602642Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy
Q35577740Covalent linking of proteins and cytokines to suture: Enhancing the immune response of head and neck cancer patients
Q41103809Cytokine expression by head and neck squamous cell carcinomas
Q38070999Emerging insights into head and neck cancer metastasis
Q40867463Immunology of head and neck cancer: perspectives
Q44295538Key architectural changes in tumor-negative lymph nodes from metastatic-free oral cancer patients are valuable prognostic factors
Q73668570Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2
Q74828892Nodal metastases: predictive factors
Q39115679Prospects for future studies in head and neck cancer
Q36820724Survival, metastasis and recurrence of oral cancer in relation to pathological features

Search more.